Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | FAAH | O00519 | 6/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.50 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.49 |
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23859828 | 0.91 | HPGD (0.73) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL3183371 | 0.91 | HPGD (0.73) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL8972518 | 0.91 | HPGD (0.73) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL9046710 | 0.91 | HPGD (0.73) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL2787821 | 0.91 | HPGD (0.73) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL3192172 | 0.89 | HPGD (0.70) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL3177576 | 0.78 | LMNA (0.77) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL22721189 | 0.78 | ALDH1A1 (0.83) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL3383085 | 0.77 | HPGD (1.00) | HPGDHDAC1MEN1NPC1ALDH1A1 | |
| SCHEMBL3967018 | 0.76 | MAPT (0.65) | HDAC1LMNAPOLBKMT2AFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2321363-B1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | MATERIA INC (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-2046719-B1 | RING OPENING CROSS-METATHESIS REACTION OF CYCLIC OLEFINS WITH SEED OILS AND THE LIKE | ELEVANCE RENEWABLE SCIENCES (US) | 2013-09-04 | — | — | EP | disclosed |
| US-8324334-B2 | Telechelic olefin metathesis polymers from renewable feedstocks | MATERIA, INC. (US) | 2012-12-04 | — | — | US | disclosed |
| US-8067623-B2 | Producing waxes from soybean oil; ruthenium alkylidene catalytic, simultaneous opening and inserting | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2011-11-29 | — | — | US | disclosed |
| EP-2321363-A1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | Materia, Inc. (US) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010021740-A1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | MATERIA, INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| EP-2046719-A2 | RING OPENING CROSS-METATHESIS REACTION OF CYCLIC OLEFINS WITH SEED OILS AND THE LIKE | Elevance Renewable Sciences, Inc. (US) | 2009-04-15 | — | — | EP | disclosed |
| US-20080064891-A1 | Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like | WILMAR TRADING PTE LTD (SG) | 2008-03-13 | — | — | US | disclosed |
| WO-2008008440-A2 | RING OPENING CROSS-METATHESIS REACTION OF CYCLIC OLEFINS WITH SEED OILS AND THE LIKE | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| US-4873351-A | REACTING ANTIMONY TRIOXIDE WITH ORGANIC MERCAPTAN IN THE PRESENCE OF A LOWER ALIPHATIC CARBOXYLIC ACID | SAKAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1989-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064891-A1 | Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like | SQLE, COASY, ALOX12 | HPGD 1300/4885HDAC1 4744/4885MEN1 3380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.